The physician was attempting to use a resolute onyx rx drug eluting stent to treat a moderately calcified and moderately tortuous mid lad lesion.No damage noted to device packaging and no issues were noted when removing the devices from the hoop/tray.The device was inspected with no issues noted.Negative prep was performed with no issues noted.The lesion was pre-dilated.During the procedure, the device passed through a previously deployed stent in the proximal section of the vessel without issue.It was reported that the stent failed to cross through a small lesion proximal to the previously deployed stent.Several attempts were made unsuccessfully.Excessive force was not used.The physician removed the device and upon inspection it was noted that a very fine fragment or hair was on the distal part of the stent.The physician assumed that it prevented the stent tracking.The guidewire used in the procedure had been successfully used for lesion prep and delivery of a previous stent without issue.No issues were noted loading the device onto the guidewire, and it was used successfully with other devices after the difficulties with the resolute onyx occurred.Another stent was used and deployed to complete the procedure.No patient injury reported.Please note that this device, resolute onyx is not marketed in the united states; however, it is similar to the united states marketed product resolute integrity.This event is being reported only as a malfunction because of the similar device requirement in 803 which is limited to malfunctions.
|